Pharmacological and toxicological properties of 19-nortestosterone-homofarnesta (DA 1979), a new anabolic agent.
D000469:Alkaline Phosphatase / Q000378:metabolism; D045930:Anabolic Agents / Q000494:pharmacology* / Q000633:toxicity; D001003:Anal Canal / Q000187:drug effects; D000818:Animals; D001769:Blood; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D002645:Chickens; D003129:Comb and Wattles / Q000187:drug effects; D005233:Fatty Alcohols / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D007668:Kidney / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009277:Nandrolone / Q000494:pharmacology* / Q000633:toxicity; D009929:Organ Size; D011467:Prostate / Q000187:drug effects; D012313:RNA / Q000378:metabolism; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects
D045930:Anabolic Agents; D005233:Fatty Alcohols; D012313:RNA; D009277:Nandrolone; D000469:Alkaline Phosphatase